NXTCNextCure, Inc.

Nasdaq nextcure.com


$ 1.67 $ -0.05 (-2.91 %)    

Friday, 10-May-2024 12:33:15 EDT
QQQ $ 441.39 $ -1.54 (-0.35 %)
DIA $ 394.86 $ -0.40 (-0.1 %)
SPY $ 520.27 $ -1.25 (-0.24 %)
TLT $ 89.98 $ -0.33 (-0.37 %)
GLD $ 218.76 $ -1.02 (-0.46 %)
$ 1.72
$ 1.66
$ 0.00 x 0
$ 0.00 x 0
$ 1.66 - $ 1.71
$ 0.98 - $ 2.57
161,487
na
47.99M
$ 0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-04-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 06-10-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-nextcure-maintains-8-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates NextCure (NASDAQ:NXTC) with a Buy and maintains $8 price target.

 needham-reiterates-buy-on-nextcure-maintains-4-price-target

Needham analyst Gil Blum reiterates NextCure (NASDAQ:NXTC) with a Buy and maintains $4 price target.

 nextcure-q1-eps-061-misses-059-estimate

NextCure (NASDAQ:NXTC) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.59) by...

 hc-wainwright--co-maintains-buy-on-nextcure-raises-price-target-to-8

HC Wainwright & Co. analyst Emily Bodnar maintains NextCure (NASDAQ:NXTC) with a Buy and raises the price target from $5...

 needham-maintains-buy-on-nextcure-maintains-4-price-target

Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and maintains $4 price target.

 nextcure-reports-fy23-eps-225-vs-269-yoy-cash-cash-equivalents-and-marketable-securities-as-of-december-31-2023-were-1083m

Financial Results for Full Year Ended December 31, 2023Cash, cash equivalents, and marketable securities as of December 31, 202...

 why-amtech-systems-shares-are-trading-higher-by-over-30-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-t...

 needham-maintains-buy-on-nextcure-lowers-price-target-to-4

Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $6 to $4.

 us-stocks-higher-initial-jobless-claims-fall-to-202000

U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION